Claret Medical Inc. hopes to take advantage of growing awareness among surgeons and interventional cardiologists of the neurological risks associated with transcatheter aortic valve replacement with its Sentinel cerebral protection device designed specifically for TAVR.
“[TAVR] expansion has happened very rapidly, but it's also generated a number of complications that have created new clinical needs,” Claret CEO Azin
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?